MyAverix Finance
SHG · Healthcare
ZhuZhou QianJin Pharmaceutical Co Ltd (600479)
Drug Manufacturers - Specialty & Generic
ZhuZhou QianJin Pharmaceutical Co Ltd (600479) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-28, reported market cap is $5.10B, P/E ratio is 16.98, net margin is 7.9%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 600479
ZhuZhou QianJin Pharmaceutical Co Ltd (600479) — FAQ
What is ZhuZhou QianJin Pharmaceutical Co Ltd's market cap?
ZhuZhou QianJin Pharmaceutical Co Ltd (600479) has a reported market cap of $5.10B (data as of 2026-03-28).
What is 600479's P/E ratio?
The price-to-earnings (P/E) ratio for ZhuZhou QianJin Pharmaceutical Co Ltd (600479) is 16.98 (data as of 2026-03-28).
Does ZhuZhou QianJin Pharmaceutical Co Ltd pay a dividend?
Dividend yield is not available in the current snapshot for ZhuZhou QianJin Pharmaceutical Co Ltd (600479). Check the MyAverix Finance app for the latest dividend data.
What sector is ZhuZhou QianJin Pharmaceutical Co Ltd in?
ZhuZhou QianJin Pharmaceutical Co Ltd (600479) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 600479 listed on?
600479 is listed on SHG.
What is ZhuZhou QianJin Pharmaceutical Co Ltd's net margin?
ZhuZhou QianJin Pharmaceutical Co Ltd (600479) reports a net margin of 7.9% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.